Twin Tree Management, LP Repligen Corp Call Options Transaction History

Twin Tree Management, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$120.0 - $182.95 $3.97 Million - $6.06 Million	-33,100 Reduced 54.89%	27,200 $3.43 Million
Q1 2024 May 09, 2024	BUY	$170.78 - $208.42 $10.3 Million - $12.6 Million	60,300 New	60,300 $11.1 Million
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $3.21 Million - $4.29 Million	-22,800 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$161.19 - $257.96 $2.18 Million - $3.48 Million	13,500 Added 145.16%	22,800 $4.29 Million
Q4 2021 Feb 10, 2022	BUY	$247.59 - $304.47 $2.3 Million - $2.83 Million	9,300 New	9,300 $2.46 Million

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.